tiprankstipranks
Cardinal Health (CH:CLH)
NYSE:CLH
Switzerland Market
CLH
Cardinal Health
RESEARCH TOOLSreports

Cardinal Health (CLH) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

CLH Analyst Ratings

Strong Buy
13Ratings
Strong Buy
12 Buy
1 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Cardinal
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CLH Stock 12 Month Forecast

Average Price Target

―
Based on 13 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is $218.00 with a high forecast of $236.99 and a low forecast of $194.79. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$236.99Average Price Target$218.00Lowest Price Target$194.79
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CH:CLH
Erin Wright
Morgan Stanley
Morgan Stanley
CHF215.08→CHF206.96
Buy
―
Reiterated
08/12/26
Morgan Stanley Sticks to Its Buy Rating for Cardinal Health (CAH)
TD Cowen Analyst forecast on CH:CLH
Charles Rhyee
TD Cowen
TD Cowen
CHF223.2→CHF227.25
Buy
―
Reiterated
08/12/26
We raise our PT to $280 (from $275), based on our DCF, which implies shares can trade at 21x our CY27 adj. EPS est. of $13.34
Evercore ISI Analyst forecast on CH:CLH
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF219.14
Buy
―
Reiterated
08/12/26
Cardinal Health (CAH) Receives a Buy from Evercore ISI
Barclays Analyst forecast on CH:CLH
Glen Santangelo
Barclays
Barclays
CHF209.4
Buy
―
Reiterated
08/12/26
Cardinal Health (CAH) Gets a Buy from Barclays
Wells Fargo Analyst forecast on CH:CLH
Stephen Baxter
Wells Fargo
Wells Fargo
CHF198.85→CHF224.82
Buy
―
Assigned
08/12/26
Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)
Citi Analyst forecast on CH:CLH
Daniel Grosslight
Citi
Citi
CHF215.08→CHF227.25
Buy
―
Reiterated
08/12/26
Citi Keeps Their Buy Rating on Cardinal Health (CAH)
Leerink Partners Analyst forecast on CH:CLH
Michael Cherny
Leerink Partners
Leerink Partners
CHF223.2→CHF236.99
Buy
―
Reiterated
08/11/26
Cardinal Health price target raised to $292 from $275 at LeerinkCardinal Health price target raised to $292 from $275 at Leerink
William Blair Analyst forecast on CH:CLH
Ryan Daniels
William Blair
William Blair
―
Buy
―
Reiterated
08/11/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Axsome Therapeutics (NASDAQ: AXSM) and BridgeBio Pharma (NASDAQ: BBIO)
Deutsche Bank Analyst forecast on CH:CLH
George Hill
Deutsche Bank
Deutsche Bank
―
Hold
―
Reiterated
08/03/26
Analysts Conflicted on These Healthcare Names: Guardant Health (NASDAQ: GH) and Cardinal Health (NYSE: CAH)
Mizuho Securities Analyst forecast on CH:CLH
Steven Valiquette
Mizuho Securities
Mizuho Securities
CHF194.79
Buy
―
Reiterated
07/28/26
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (NASDAQ: MEDP), NeuroPace (NASDAQ: NPCE) and Cardinal Health (NYSE: CAH)
Bank of America Securities Analyst forecast on CH:CLH
Allen Lutz
Bank of America Securities
Bank of America Securities
CHF211.02
Buy
―
Reiterated
07/20/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NASDAQ: NEOG) and Cardinal Health (NYSE: CAH)
UBS Analyst forecast on CH:CLH
Kevin Caliendo
UBS
UBS
CHF211.02→CHF222.38
Buy
―
Assigned
07/20/26
Cardinal Health price target raised to $274 from $260 at UBSCardinal Health price target raised to $274 from $260 at UBS
William O'Neil Analyst forecast on CH:CLH
Unknown Analyst
William O'Neil
Not Ranked
William O'Neil
―
Buy
―
Initiated
06/12/26
Cardinal Health (CAH) Gets a Buy from William O'Neil
Argus Research Analyst forecast on CH:CLH
Steven Silver
Argus Research
Argus Research
CHF201.28
Buy
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH) and Dexcom (NASDAQ: DXCM)
J.P. Morgan Analyst forecast on CH:CLH
Lisa Gill
J.P. Morgan
J.P. Morgan
CHF197.22→CHF174.5
Hold
―
Assigned
05/04/26
Cardinal Health price target lowered to $215 from $243 at JPMorganCardinal Health price target lowered to $215 from $243 at JPMorgan
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CH:CLH
Erin Wright
Morgan Stanley
Morgan Stanley
CHF215.08→CHF206.96
Buy
―
Reiterated
08/12/26
Morgan Stanley Sticks to Its Buy Rating for Cardinal Health (CAH)
TD Cowen Analyst forecast on CH:CLH
Charles Rhyee
TD Cowen
TD Cowen
CHF223.2→CHF227.25
Buy
―
Reiterated
08/12/26
We raise our PT to $280 (from $275), based on our DCF, which implies shares can trade at 21x our CY27 adj. EPS est. of $13.34
Evercore ISI Analyst forecast on CH:CLH
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF219.14
Buy
―
Reiterated
08/12/26
Cardinal Health (CAH) Receives a Buy from Evercore ISI
Barclays Analyst forecast on CH:CLH
Glen Santangelo
Barclays
Barclays
CHF209.4
Buy
―
Reiterated
08/12/26
Cardinal Health (CAH) Gets a Buy from Barclays
Wells Fargo Analyst forecast on CH:CLH
Stephen Baxter
Wells Fargo
Wells Fargo
CHF198.85→CHF224.82
Buy
―
Assigned
08/12/26
Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)
Citi Analyst forecast on CH:CLH
Daniel Grosslight
Citi
Citi
CHF215.08→CHF227.25
Buy
―
Reiterated
08/12/26
Citi Keeps Their Buy Rating on Cardinal Health (CAH)
Leerink Partners Analyst forecast on CH:CLH
Michael Cherny
Leerink Partners
Leerink Partners
CHF223.2→CHF236.99
Buy
―
Reiterated
08/11/26
Cardinal Health price target raised to $292 from $275 at LeerinkCardinal Health price target raised to $292 from $275 at Leerink
William Blair Analyst forecast on CH:CLH
Ryan Daniels
William Blair
William Blair
―
Buy
―
Reiterated
08/11/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Axsome Therapeutics (NASDAQ: AXSM) and BridgeBio Pharma (NASDAQ: BBIO)
Deutsche Bank Analyst forecast on CH:CLH
George Hill
Deutsche Bank
Deutsche Bank
―
Hold
―
Reiterated
08/03/26
Analysts Conflicted on These Healthcare Names: Guardant Health (NASDAQ: GH) and Cardinal Health (NYSE: CAH)
Mizuho Securities Analyst forecast on CH:CLH
Steven Valiquette
Mizuho Securities
Mizuho Securities
CHF194.79
Buy
―
Reiterated
07/28/26
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (NASDAQ: MEDP), NeuroPace (NASDAQ: NPCE) and Cardinal Health (NYSE: CAH)
Bank of America Securities Analyst forecast on CH:CLH
Allen Lutz
Bank of America Securities
Bank of America Securities
CHF211.02
Buy
―
Reiterated
07/20/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NASDAQ: NEOG) and Cardinal Health (NYSE: CAH)
UBS Analyst forecast on CH:CLH
Kevin Caliendo
UBS
UBS
CHF211.02→CHF222.38
Buy
―
Assigned
07/20/26
Cardinal Health price target raised to $274 from $260 at UBSCardinal Health price target raised to $274 from $260 at UBS
William O'Neil Analyst forecast on CH:CLH
Unknown Analyst
William O'Neil
Not Ranked
William O'Neil
―
Buy
―
Initiated
06/12/26
Cardinal Health (CAH) Gets a Buy from William O'Neil
Argus Research Analyst forecast on CH:CLH
Steven Silver
Argus Research
Argus Research
CHF201.28
Buy
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH) and Dexcom (NASDAQ: DXCM)
J.P. Morgan Analyst forecast on CH:CLH
Lisa Gill
J.P. Morgan
J.P. Morgan
CHF197.22→CHF174.5
Hold
―
Assigned
05/04/26
Cardinal Health price target lowered to $215 from $243 at JPMorganCardinal Health price target lowered to $215 from $243 at JPMorgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
TNYATenaya Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cardinal Health

3 Months
Eric ColdwellRobert W. Baird
Success Rate
20/27 ratings generated profit
74%
Average Return
+6.33%
Copying Eric Coldwell's trades and holding each position for 3 Months would result in 74.07% of your transactions generating a profit, with an average return of +6.33% per trade.
1 Year
Kevin CaliendoUBS
Success Rate
19/19 ratings generated profit
100%
Average Return
+29.91%
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +29.91% per trade.
2 Years
Kevin CaliendoUBS
Success Rate
19/19 ratings generated profit
100%
Average Return
+73.77%
Copying Kevin Caliendo's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +73.77% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CLH Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
17
13
14
16
17
Hold
2
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
14
15
17
18
In the current month, CLH has received 17 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CLH average Analyst price target in the past 3 months is 218.00.
Each month's total comprises the sum of three months' worth of ratings.

CLH Financial Forecast

CLH Earnings Forecast

Next quarter’s earnings estimate for CLH is $2.40 with a range of $2.34 to $2.51. The previous quarter’s EPS was $2.36. CLH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.51% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.
Next quarter’s earnings estimate for CLH is $2.40 with a range of $2.34 to $2.51. The previous quarter’s EPS was $2.36. CLH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.51% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.

CLH Sales Forecast

Next quarter’s sales forecast for CLH is $54.42B with a range of $52.82B to $56.24B. The previous quarter’s sales results were $51.68B. CLH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.92% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.
Next quarter’s sales forecast for CLH is $54.42B with a range of $52.82B to $56.24B. The previous quarter’s sales results were $51.68B. CLH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.92% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.

CLH Stock Forecast FAQ

What is CH:CLH’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardinal Health’s 12-month average price target is 218.00.
    What is CH:CLH’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:CLH, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Cardinal Health a Buy, Sell or Hold?
        Cardinal Health has a consensus rating of Strong Buy, which is based on 12 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Cardinal Health’s share price target?
          The average share price target for Cardinal Health is 218.00. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $236.99 ,and the lowest forecast is $194.79. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Cardinal Health?
            Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
              How can I buy shares of Cardinal Health?
              To buy shares of CH:CLH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.